enVVeno Medical (NASDAQ: HJLI)
$5.23
(0.2%)
$0.01
Price as of April 25, 2024, 4:00 p.m. ET
enVVeno Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
enVVeno Medical Company Info
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.